You just read:

AMG 277 Discriminates Against S1P3 Receptor by 50-fold. S1P1 Lead Compounds Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale. Assets Generated by Epix Pharmaceuticals, Inc. and Amgen.

News provided by

Joseph F. Finn, Jr., C.P.A.

29 Nov, 2011, 18:44 GMT